Showing results (961-970 of 1,387) with videos related to

Sort By:
Pageof 139
Oral Oncology|November 24, 2020
Gender and race interact to influence survival disparities in head and neck cancerAngela L Mazul, Akash N Naik, Kevin Y Zhan, et al.
Journal of Health Care for the Poor and Underserved|October 17, 2022
The Impact of the Affordable Care Act on Insurance Coverage and Stage Among Head and Neck Squamous Cell Carcinoma PatientsKrupal B Patel, Sepehr Shabani, Tapan Padhya, et al.
Communications Biology|February 16, 2020
An isothermal shift assay for proteome scale drug-target identificationKerri A Ball, Kristofor J Webb, Stephen J Coleman, et al.
Journal of Shoulder and Elbow Surgery|May 22, 2021
Effect of age, gender, and body mass index on incidence and satisfaction of a Popeye deformity following biceps tenotomy or tenodesis: secondary analysis of a randomized clinical trialJarret M Woodmass, Sheila M B McRae, Peter L Lapner, et al.
Immunity|September 12, 2000
Eradication of established tumors by CD8+ T cell adoptive immunotherapyH L Hanson, D L Donermeyer, H Ikeda, et al.
British Journal of Cancer|August 17, 2000
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumoursA A Jungbluth, E Stockert, Y T Chen, et al.
International Journal of Cancer|May 15, 2001
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissuesA A Jungbluth, Y T Chen, E Stockert, et al.
BMC Genomics|October 22, 2010
Use of consensus sequences for the design of high density resequencing microarrays: the influenza virus paradigmIndia Leclercq, Nicolas Berthet, Christophe Batéjat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2010
Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patientsJulia Karbach, Antje Neumann, Akin Atmaca, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 10, 2012
Novel mechanistic insights into arginine deiminase pharmacology suggest 18F-FDG is not suitable to evaluate clinical response in melanomaLars Stelter, Michael J Evans, Achim A Jungbluth, et al.
Pageof 139